Startseite>>Signaling Pathways>> Tyrosine Kinase>> Insulin Receptor>>Acetyl Gastric Inhibitory Peptide (human) (TFA)

Acetyl Gastric Inhibitory Peptide (human) (TFA) (Synonyms: Human N-acetyl GIP TFA)

Katalog-Nr.GC68604

Acetyl Gastric Inhibitory Peptid (human) TFA ist ein fettähnliches Derivat des glukoseabhängigen Insulin-Polypeptids mit verbesserten antihyperglykämischen und insulinotropen Eigenschaften. Acetyl Gastric Inhibitory Peptide (human) TFA kann für die Erforschung von Diabetes, Insulinresistenz und Fettleibigkeit verwendet werden.

Products are for research use only. Not for human use. We do not sell to patients.

Acetyl Gastric Inhibitory Peptide (human) (TFA) Chemische Struktur

Größe Preis Lagerbestand Menge
5mg
234,00 $
Auf Lager
10mg
369,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Bewertungen

Review for Acetyl Gastric Inhibitory Peptide (human) (TFA)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Acetyl Gastric Inhibitory Peptide (human) (TFA)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.